Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY) Sees Significant Increase in Short Interest

Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHYGet Rating) was the recipient of a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 26,300 shares, a growth of 87.9% from the March 15th total of 14,000 shares. Based on an average daily volume of 89,200 shares, the days-to-cover ratio is currently 0.3 days.

Shares of OTCMKTS:SNPHY opened at $8.70 on Friday. The company has a 50 day moving average of $10.66 and a 200 day moving average of $12.13. Santen Pharmaceutical has a 12 month low of $8.60 and a 12 month high of $15.70.

Separately, Jefferies Financial Group upgraded shares of Santen Pharmaceutical from a “hold” rating to a “buy” rating in a research report on Friday.

About Santen Pharmaceutical (Get Rating)

Santen Pharmaceutical Co, Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the following segments: Pharmaceuticals and Others. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products.

Further Reading

Receive News & Ratings for Santen Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santen Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.